I especially thank the dedicated personnel from WHO and our partners who are working around the clock in extreme circumstances, including in the Democratic Republic of the Congo, Mozambique and Yemen.
6402
医疗产品警报2019 年第11 期
Medical Product Alert N° 11/2019:
6403
2019年10月16日 | 医疗产品警报
16 October 2019 | Medical product alert
6404
伪造的阿莫西林+克拉维酸产品在海地流通
Falsified Amoxicillin + Clavulanic Acid products Falsified Amoxicillin + Clavulanic Acid products circulating in Haiti
This Medical Product Alert relates to two confirmed falsified versions of amoxicillin + clavulanic acid products circulating in Haiti, presented under the names “Augmentin and Amoxicillin Clavulanate Potassium” and “Bactoclav”.
6406
正宗的阿莫西林+克拉维酸用来治疗一系列细菌感染,并以“可用类”抗生素被列入世卫组织基本 药物清单。
Genuine amoxicillin + clavulanic acid is used to treat a range of bacterial infections and is referenced on the WHO Essential Medicines List as an access group antibiotic.
WHO was informed by the Haiti Ministère de la Santé Publique et de la Population (MSPP) and Caribbean Public Health Agency’s (CARPHA) VigiCarib network (which is a regional reporting system for pharmacovigilance and post market surveillance), that falsified “Augmentin and Amoxicillin Clavulanate Potassium” and “Bactoclav” were found in a pharmacy in Haiti.
6408
在现阶段,正在加紧对这些产品进行实验室检测。
At this stage, laboratory testing of these products is being facilitated.